Page 165 - Access Program News Today

Highlights Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been...

New vaccines are being developed to boost immunity against the XBB.1.5 subvariant of COVID-19. There are no official timelines for the rollout of any of the new boosters yet.

Scoop Community provides New Zealand Community news and views

Talent has announced a brand-new internal initiative aimed at helping youth employment. The 1 in 10 pledge states that for every 10 Talent employees, there will be 1 Talent team member globally that is RISE related (RISE team and RISE young people placed ...

Business Scoop provides news and views on Business and Markets from New Zealand

Scoop Auckland provides news and views from Auckland, New Zealand

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and...

FDA indicated that approval of MAT2203 as a first-line treatment for invasive aspergillosis will require an adequately powered study with an active control group and an all-cause mortality...

NEW YORK, Aug. 9, 2023 /PRNewswire/ -- Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business...

Value and versatility of underutilized pork, beef and lamb cuts were a focus of the event.